Cologuard Plus™ test raises the performance bar with sensitivities of 95% for colorectal cancer and 43% for advanced precancerous lesions at 94% specificity
Cologuard Plus test will minimize unnecessary follow-up colonoscopies by reducing the likelihood of a false-positive screening test
Company expects to launch Cologuard Plus test with Medicare coverage and guideline inclusion in 2025
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.